These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 23726604

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.
    Kolonko A, Chudek J, Wiecek A.
    Transplant Proc; 2011 Oct; 43(8):2950-3. PubMed ID: 21996198
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus.
    Lauzurica R, Morales JM, van Hooff J, Study Investigators.
    Transpl Int; 2012 Jan; 25(1):48-55. PubMed ID: 21992068
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    van Hooff J, Van der Walt I, Kallmeyer J, Miller D, Dawood S, Moosa MR, Christiaans M, Karpf C, Undre N.
    Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
    Meçule A, Tinti F, Poli L, Bachetoni A, Umbro I, Nofroni I, Lai Q, Pretagostini R, Berloco PB, Mitterhofer AP.
    Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
    Nakamura Y, Hama K, Katayama H, Soga A, Toraishi T, Yokoyama T, Kihara Y, Jojima Y, Konno O, Iwamoto H, Takeuchi H, Hirano T, Shimazu M.
    Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early or Late Conversion From Tac-BD to Tac-BD in Renal Transplantation: When is the Right Time?
    Falconer SJ, Peagam WR, Oniscu GC.
    Transplant Proc; 2015 Jan; 47(6):1741-5. PubMed ID: 26293044
    [Abstract] [Full Text] [Related]

  • 12. Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up.
    Giannelli V, Rossi M, Giusto M, Lucidi C, Lattanzi B, Ruffa A, Ginanni Corradini S, Mennini G, Melandro F, Lai Q, Berloco P, Merli M.
    Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2718-20. PubMed ID: 24174352
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan.
    Takahashi K, Abe R, Usuki S, So M.
    Transplant Proc; 2014 Oct; 46(2):406-10. PubMed ID: 24655975
    [Abstract] [Full Text] [Related]

  • 15. Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus.
    Tsuchiya T, Ishida H, Tanabe T, Shimizu T, Honda K, Omoto K, Tanabe K.
    Transplantation; 2013 Jul 27; 96(2):198-204. PubMed ID: 23792649
    [Abstract] [Full Text] [Related]

  • 16. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
    Florman S, Alloway R, Kalayoglu M, Punch J, Bak T, Melancon J, Klintmalm G, Busque S, Charlton M, Lake J, Dhadda S, Wisemandle K, Wirth M, Fitzsimmons W, Holman J, First MR.
    Transplantation; 2007 Jun 27; 83(12):1639-42. PubMed ID: 17589349
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.
    Uemoto S, Abe R, Horike H, So M.
    Transplant Proc; 2014 Apr 27; 46(3):749-53. PubMed ID: 24767340
    [Abstract] [Full Text] [Related]

  • 18. Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature.
    Tran D, Vallée M, Collette S, Senécal L, Lafrance JP, Dandavino R, Boucher A.
    Exp Clin Transplant; 2014 Aug 27; 12(4):323-7. PubMed ID: 24844288
    [Abstract] [Full Text] [Related]

  • 19. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
    Niioka T, Satoh S, Kagaya H, Numakura K, Inoue T, Saito M, Narita S, Tsuchiya N, Habuchi T, Miura M.
    Transplantation; 2012 Nov 27; 94(10):1013-9. PubMed ID: 23073468
    [Abstract] [Full Text] [Related]

  • 20. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
    Alloway R, Steinberg S, Khalil K, Gourishankar S, Miller J, Norman D, Hariharan S, Pirsch J, Matas A, Zaltzman J, Wisemandle K, Fitzsimmons W, First MR.
    Transplant Proc; 2005 Mar 27; 37(2):867-70. PubMed ID: 15848559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.